Best in Biotech 1 Dec 2025 Stem cell therapy’s avant-garde: Eight companies leading the way …Aspen Neuroscience Founded: 2018 Headquarters: San Diego, California, U.S. Lead candidate: ANPD001 Founded in 2018 and headquartered in San Diego, Aspen Neuroscience is a clinical-stage biotech developing personalized, autologous stem-cell… December 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 1 Aug 2022 Ipsen and Marengo Therapeutics partner to push immuno-oncology candidates into the clinic Ipsen and Marengo Therapeutics, Inc. have announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic. Ipsen also announced it is exercising its option… August 1, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2025 Six key obesity deals in 2025 …of GPCRs in purified biochemical formats. Both companies will jointly conduct research activities from discovery through to development candidate selection. Then, when the candidates reach investigational new drug (IND)-enabling activities, Novo will… November 21, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2023 The promise of immunotherapy for autoimmune diseases …drug, 1104. The candidate binds to monocytes – which mature into dendritic cells – and modifies the regulatory signal that causes them to activate regulatory dendritic cells, regulatory T cells… June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 23 Oct 2017 FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation TiGenix’s candidate for a nasty Crohn’s disease complication received orphan drug designation after agreeing on a global Phase III trial. TiGenix exploits the anti-inflammatory properties of donor-derived stem cells to… October 23, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 16 Aug 2022 Remedium raises more funds for osteoarthritis gene therapy candidate …candidate is the only single injection gene therapy based on the clinically proven anabolic mechanism of FGF18, which has demonstrated the ability to reverse cartilage loss in a placebo controlled,… August 16, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jun 2023 NodThera announces positive inflammatory disease data NodThera has announced positive data from first-in-human studies of its lead therapeutic candidates, NT-0249 and NT-0796. In the studies, both candidates were shown to clearly inhibit the NLRP3 inflammasome, a… June 20, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jul 2022 Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease …targeting food allergies and inflammatory bowel disease (IBD). The collaboration aims to develop and commercialize Enterome’s lead EndoMimics pipeline candidate EB1010. EB1010 is a local inducer of IL-10 designed to… July 18, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 23 Jan 2025 mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics …only got into proteins and antibodies when it was already a $20 billion market,” said Greene, back in 2017. And while Alnylam suffered some setbacks itself, including an earlier candidate… January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2019 European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm …candidate, temelimab. This antibody drug is being developed to prevent relapses in multiple sclerosis. In total, 220 patients took part in the extension study for 96 weeks. The patients given… September 17, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2023 Biocytogen launches nanobody therapeutics project for 100 targets …therapy, bispecific antibody and engager, multi-specific antibody, antibody drug-conjugate (ADC), and radionuclide antibody-conjugate (RAC). After several years of work, Biocytogen successfully engineered the RenNano mouse from its fully human antibody… February 21, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Aug 2022 AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery …The collaboration leverages Atlas’ track record in forming innovative biotech companies, and AbCellera’s ability to quickly deliver lead drug candidates to bring transformational new medicines to patients faster. “AbCellera’s clinically… August 3, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email